Manifold MarketsKYC yokDoğrulanmış sonuçlanma verisiOrta düzey kalibreGüncel topluluk tahminiHayır 96%
Tahminciler
39
Soru türü
binary
Yöntem
Play-money forecasting platform
Kaynak türü
Tahmin
Piyasa verileri
46 dakika önce güncellendi
Gecikmeli8 May 26 22:38 UTC31 Ara 26 23:59 UTC
Trendler
İlgili Piyasalar
Bağlam için ilgili sorular; eşdeğer sözleşmelerin karşılaştırması değildir.
Hantavirus vaccine in 2026?
PolymarketWhen will the FDA reclassify BPC-157 to Category 1?
KalshiHantavirus pandemic in 2026?
PolymarketEbola pandemic in 2026?
PolymarketHow many West Nile neuroinvasive disease cases will be reported among New York City residents in 2026?
PolymarketWill WHO declare Hantavirus a Public Health Emergency of International Concern this Year?
KalshiKurallar
This question will be resolved alongside the corresponding market on Polymarket: https://polymarket.com/event/hantavirus-vaccine-in-2026
- Resolution criteria
- This market will resolve to "Yes" if any vaccine intended for humans and inoculating against Hantavirus (including Hantavirus Pulmonary Syndrome (HPS) or Hemorrhagic Fever with Renal Syndrome (HFRS)) receives full approval from the U.S. Food and Drug Administration between market creation and December 31, 2026, 11:59 PM ET.
- Otherwise, this market will resolve to "No".
- The primary resolution source for this market will be official information from the FDA, including its list of approved vaccines (https://www.fda.gov/vaccines-blood-biologics/vaccines/vaccines-licensed-use-united-states), however a consensus of credible reporting may also be used.
- Hantaviruses are a family of viruses spread mainly by rodents and can cause varied disease syndromes in people worldwide.